NEWS
SUBSCRIBER SEARCH (Requires Login)
  NEW DRUGS
  MARKETED DRUGS
  COMPANY
  TARGETS IN ONCOLOGY
  NEWS SUMMARIES
  COMBINATION TRIALS

Latest Updates

December 2009 Marketed Drug Updates and Additions

Brand Name

Generic Name

Other Designation

Lupron, Lupron Depot, Leuplin (Japan), Lucrin, Enantone (Germany), Prostap

Leuprolide acetate, leuprorelin

TAP-144SR

Cetrotide (IVF fertility)

Cetrorelix

SB-75, SB-075

Folotyn

Pralatrexate

PDX

Iressa

Gefitinib

ZD1839, ZD-1839

AC Vaccine M-Vax (Mela Vax)

 

 

Evista • Optruma (Europe, formerly Celvista)

Raloxifene

 

Arzerra

Ofatumumab

HuMax-CD20, GSK1841157

Votrient (formerly Armala)

Pazopanib HCl

GW786034, 786034

Istodax

Romidepsin

FR901228, FK228, NSC630176

Tarceva

Erlotinib

CP 358774, OSI-774, R1415, RG1415, NSC 718781

Yondelis

Trabectedin

Ecteinascidin 743, ET-743, NSC 648766

Endu, Endostar

 

 

  

Home   |    Freelance Opportunities   |   New Medicine   |   Site Map   |  Order/Inquiry   
SUBSCRIBER SEARCH:   NEW DRUG   |   MARKETED DRUG   |   COMPANY   |   TARGETS IN ONCOLOGY  

NEW MEDICINE, INC.
P.O. BOX 909, LAKE FOREST, CA 92609
PHONE:  1-949-830-0448     FAX:  1-949-830-0887
INFO@NEWMEDINC.COM